Avenue Therapeutics Inc. (ATXI) at a glance
Avenue Therapeutics Inc. (ATXI) is a micro-cap Healthcare company. It trades at $0.32, with a P/E of 0.4 and a -124.8% profit margin. It does not pay a dividend. Vestovix scores it 63/100 overall. Its strongest dimension is Value (89/100) and its weakest is Momentum (28/100). It is a relatively defensive holding with below-market volatility.
- Price
- $0.32
- Market cap
- $1.1M
- P/E ratio
- 0.4
- Dividend yield
- None
- Beta
- -0.17
- 52-week range
- $0.15 to $0.97
Value
89
Growth
50
Income
40
Safety
86
Momentum
28
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,152.90-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$270.26+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$264.03-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$375.83-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$147.13-0.98%
2.79% yield
ABT54
Abbott Laboratories
$102.24+0.92%
2.16% yield
AMGN65
Amgen Inc.
$379.75-1.05%
2.76% yield